Columbus Circle Investors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$11.3M Buy
59,147
+284
+0.5% +$51.7K 0.5% 83
2020
Q3
$8.69M Buy
58,863
+15,686
+36% +$2.24M 0.38% 95
2020
Q2
$5.34M Buy
+43,177
New +$5.08M 0.21% 126
2016
Q4
Sell
-11,810
Closed -$357K 291
2016
Q3
$357K Buy
+11,810
New +$356K ﹤0.01% 267
2016
Q2
Sell
-352,318
Closed -$9.45M 285
2016
Q1
$9.45M Sell
352,318
-220,414
-38% -$5.39M 0.08% 183
2015
Q4
$16.2M Buy
572,732
+150,123
+36% +$4.33M 0.13% 155
2015
Q3
$11.8M Buy
422,609
+227,255
+116% +$8.21M 0.1% 177
2015
Q2
$8.06M Buy
+195,354
New +$7.16M 0.06% 218

Other funds holding RGEN

Columbus Circle Investors's RGEN Position: Q4 2020 in Review

Columbus Circle Investors increased its Repligen (RGEN) stake by 0.48% in Q4 2020, buying an estimated $51.7K and bringing the position to 59,147 shares worth $11.3M. The position accounts for 0.5% of the portfolio, ranked #83.

Columbus Circle Investors first reported a position in RGEN in Q2 2015 and has held it in 8 quarters since. The position peaked at $16.2M in Q4 2015. 449 funds tracked by Wall St. Rank hold RGEN as of Q4 2020.

  • Columbus Circle Investors held 59,147 shares of Repligen worth $11.3M as of Q4 2020.
  • Columbus Circle Investors bought 284 Repligen shares in Q4 2020, an estimated $51.7K.
  • Repligen made up 0.5% of Columbus Circle Investors's portfolio in Q4 2020, its #83 holding.
  • Columbus Circle Investors first reported a position in Repligen in Q2 2015 and has held it in 8 quarters since.
  • Columbus Circle Investors's Repligen position peaked at $16.2M in Q4 2015.
  • 449 funds tracked by Wall St. Rank held Repligen as of Q4 2020.

Based on Columbus Circle Investors's 13F filing for Q4 2020, filed 20 Jan 2021.